Latest News from Arcinova

stdClass Object ( [id] => 72 [title] => Welcome to Mark Chadwick [alias] => welcome-to-mark-chadwick [title_alias] => [introtext] =>

Welcoming Arcinova's Head of Business Development

 

 

[language] => * [fulltext] =>

Mark joins Arcinova from AIM-listed Physiomics plc, where he was CEO for 5 years. Mark’s previous roles include CEO of Envirogene and VP of Business Development at Excelsyn. Before joining Excelsyn, Mark spent 10 years in Cambridge from startup company (Cambridge Genetics Limited) through two mergers to become Director of Commercial Operations at BioFocus, a drug discovery services provider which was subsequently acquired by Galapagos. Mark holds a degree in Genetics from the University of Nottingham, a PhD in Molecular Biology from the University of Newcastle and an MBA from Imperial College London. 

Ian Shott, Arcinova Managing Director, commented "I've known Mark for many years and watched his career develop and I am delighted he is now joining us in this critical role".  

Mark Chadwick added "I am extremely enthusiastic to be joining the Arcinova team. The facilities are second-to-none with great potential to develop the business".

 

 

[checked_out] => 0 [checked_out_time] => 0000-00-00 00:00:00 [catid] => 9 [created] => 2016-04-14 17:51:02 [created_by] => 853 [created_by_alias] => [modified] => 2018-07-06 14:03:47 [modified_by] => 849 [modified_by_name] => tr10.support [publish_up] => 2016-04-14 17:51:02 [publish_down] => 0000-00-00 00:00:00 [images] => {"image_intro":"images\/Arcinova-MarkChadwick-HeadShot-Square-1.png","float_intro":"","image_intro_alt":"","image_intro_caption":"","image_fulltext":"","float_fulltext":"","image_fulltext_alt":"","image_fulltext_caption":""} [urls] => {"urla":false,"urlatext":"","targeta":"","urlb":false,"urlbtext":"","targetb":"","urlc":false,"urlctext":"","targetc":""} [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [metadata] => {"robots":"","author":"","rights":"","xreference":""} [metakey] => [metadesc] => Mark joins us from AIM-listed Physiomics plc, where he was CEO for 5 yrs. His previous roles include CEO of Envirogene and VP of Business Dev at Excelsyn. [access] => 1 [hits] => 2076 [xreference] => [featured] => 0 [readmore] => 1261 [state] => 1 [category_title] => News [category_route] => news [category_access] => 1 [category_alias] => news [author] => Sally Old [author_email] => Sally.Old@arcinova.uk [contactid] => [parent_title] => ROOT [parent_id] => 1 [parent_route] => [parent_alias] => root [rating] => [rating_count] => [published] => 1 [parents_published] => 1 [alternative_readmore] => [layout] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 0 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 0 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 0 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 1 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => none [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 1 [show_category_title] => 0 [show_description] => 1 [show_description_image] => 0 [maxLevel] => 1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 0 [show_base_description] => 1 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 0 [num_intro_articles] => 9 [num_columns] => 3 [num_links] => 0 [multi_column_order] => 1 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => order [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [layout_type] => blog [menu_text] => 1 [page_title] => Latest News from Arcinova [show_page_heading] => 0 [pageclass_sfx] => news [menu-meta_description] => Find out the most recent news from the team at Arcinova. [secure] => 0 [page_description] => [page_rights] => [robots] => [access-view] => 1 ) ) [displayDate] => 2016-04-14 17:51:02 [slug] => 72:welcome-to-mark-chadwick [parent_slug] => [catslug] => 9:news [event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) [text] =>

Welcoming Arcinova's Head of Business Development

 

 

)

stdClass Object ( [id] => 35 [title] => Evening Chronicle Article [alias] => evening-chronicle-article [title_alias] => [introtext] =>

Fifty Northumberland jobs protected after businessmen save pharmaceutical plant marked for the axe.

 

[language] => * [fulltext] =>

Last month the Evening Chronicle featured an article regarding the formation of ARC Trinova & Arcinova. The article explains that the formation of ARC Trinova, trading as Arcinova, has saved fifty jobs following the decision from Sanofi to close the Covance site in Alnwick. 

Anne-Marie Trevelyan, MP for Berwick-upon-Tweed, said: “It is good news for Alnwick and Northumberland that we will be retaining ground-breaking drug development capabilities in our area.

 

“I thank the Office for Life Sciences, and the Life Sciences Minister George Freeman, for the assistance and resources they have put in alongside the local taskforce, whose support has been excellent.

 

“It is also good to hear that a minimum of 50 of the talented workforce will stay on, and that the taskforce remains on hand to offer assistance to staff.

 

“I will continue to offer all the support I can throughout the transition process, and I have received assurances from the minister that his office remains at the disposal of the taskforce.”

 

Click here to read the full article.

[checked_out] => 0 [checked_out_time] => 0000-00-00 00:00:00 [catid] => 9 [created] => 2016-03-16 14:53:54 [created_by] => 849 [created_by_alias] => [modified] => 2016-11-21 11:37:24 [modified_by] => 849 [modified_by_name] => tr10.support [publish_up] => 2016-03-16 14:53:54 [publish_down] => 0000-00-00 00:00:00 [images] => {"image_intro":"images\/ArcinovaChronicleArticle-245x245.jpg","float_intro":"","image_intro_alt":"","image_intro_caption":"","image_fulltext":"images\/ArcinovaChronicleArticle-245x245.jpg","float_fulltext":"","image_fulltext_alt":"","image_fulltext_caption":""} [urls] => {"urla":false,"urlatext":"","targeta":"","urlb":false,"urlbtext":"","targetb":"","urlc":false,"urlctext":"","targetc":""} [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [metadata] => {"robots":"","author":"","rights":"","xreference":""} [metakey] => [metadesc] => Fifty Northumberland jobs protected after businessmen save pharmaceutical plant marked for the axe. [access] => 1 [hits] => 1408 [xreference] => [featured] => 0 [readmore] => 1310 [state] => 1 [category_title] => News [category_route] => news [category_access] => 1 [category_alias] => news [author] => tr10.support [author_email] => support@tr10.com [contactid] => [parent_title] => ROOT [parent_id] => 1 [parent_route] => [parent_alias] => root [rating] => [rating_count] => [published] => 1 [parents_published] => 1 [alternative_readmore] => [layout] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 0 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 0 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 0 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 1 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => none [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 1 [show_category_title] => 0 [show_description] => 1 [show_description_image] => 0 [maxLevel] => 1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 0 [show_base_description] => 1 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 0 [num_intro_articles] => 9 [num_columns] => 3 [num_links] => 0 [multi_column_order] => 1 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => order [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [layout_type] => blog [menu_text] => 1 [page_title] => Latest News from Arcinova [show_page_heading] => 0 [pageclass_sfx] => news [menu-meta_description] => Find out the most recent news from the team at Arcinova. [secure] => 0 [page_description] => [page_rights] => [robots] => [access-view] => 1 ) ) [displayDate] => 2016-03-16 14:53:54 [slug] => 35:evening-chronicle-article [parent_slug] => [catslug] => 9:news [event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) [text] =>

Fifty Northumberland jobs protected after businessmen save pharmaceutical plant marked for the axe.

 

)

stdClass Object ( [id] => 33 [title] => Meet the team [alias] => meet-the-team [title_alias] => [introtext] =>

As with any restructuring, people and positions in the business have changed at Arcinova. There have been some exciting changes and we'd like to introduce you to the leadership team.

[language] => * [fulltext] =>

As with any restructuring, people and positions in the business have changed at Arcinova. There have been some exciting changes and we'd like to introduce you to the new leadership team.

Ian Shott

Executive Chairman and Managing Director of Arcinova

"I’m an entrepreneur and an engineer. I love working with small technology businesses with untapped potential. We use our knowledge, experience, tools, judgement and global networks to accelerate value creation and sustainable growth”

---

Paul Ryan

Chief Financial Officer of Arcinova

“I’m a pragmatic finance professional focused on cash, customers, common sense! I enjoy using my deep financial experience and extensive tool kit to help achieve significant results quickly”

---

Martin Gray

Head of Small Molecule CMC Operations

“Having worked in both major Pharma and contract organisations allows me to look at client problems and needs from a range of perspectives. I particularly enjoy bringing this experience to bear in a working environment where there is a clear link between ideas and their rapid translation into CMC solutions for all concerned”

---

Ian Wind

Head of Engineering and Facilities

“I gain a great deal of satisfaction in being able to work and develop teams to constantly improve the working environment and business efficiencies but at the same time ensuring that the required standards are achieved"

---

Visit the People page to find out more

[checked_out] => 0 [checked_out_time] => 0000-00-00 00:00:00 [catid] => 9 [created] => 2016-02-03 13:04:41 [created_by] => 849 [created_by_alias] => [modified] => 2017-07-18 16:16:50 [modified_by] => 859 [modified_by_name] => Faye Coates [publish_up] => 2016-02-03 13:04:41 [publish_down] => 0000-00-00 00:00:00 [images] => {"image_intro":"images\/Arcinova-Ian-Shott-HeadShot-Square.png","float_intro":"","image_intro_alt":"","image_intro_caption":"","image_fulltext":"","float_fulltext":"","image_fulltext_alt":"","image_fulltext_caption":""} [urls] => {"urla":false,"urlatext":"","targeta":"","urlb":false,"urlbtext":"","targetb":"","urlc":false,"urlctext":"","targetc":""} [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [metadata] => {"robots":"","author":"","rights":"","xreference":""} [metakey] => [metadesc] => As with any restructuring, people and positions in the business have changed at Arcinova. We'd like to introduce you to the leadership team. [access] => 1 [hits] => 2702 [xreference] => [featured] => 0 [readmore] => 3179 [state] => 1 [category_title] => News [category_route] => news [category_access] => 1 [category_alias] => news [author] => tr10.support [author_email] => support@tr10.com [contactid] => [parent_title] => ROOT [parent_id] => 1 [parent_route] => [parent_alias] => root [rating] => [rating_count] => [published] => 1 [parents_published] => 1 [alternative_readmore] => [layout] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 0 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 0 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 0 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 1 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => none [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 1 [show_category_title] => 0 [show_description] => 1 [show_description_image] => 0 [maxLevel] => 1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 0 [show_base_description] => 1 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 0 [num_intro_articles] => 9 [num_columns] => 3 [num_links] => 0 [multi_column_order] => 1 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => order [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [layout_type] => blog [menu_text] => 1 [page_title] => Latest News from Arcinova [show_page_heading] => 0 [pageclass_sfx] => news [menu-meta_description] => Find out the most recent news from the team at Arcinova. [secure] => 0 [page_description] => [page_rights] => [robots] => [access-view] => 1 ) ) [displayDate] => 2016-02-03 13:04:41 [slug] => 33:meet-the-team [parent_slug] => [catslug] => 9:news [event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) [text] =>

As with any restructuring, people and positions in the business have changed at Arcinova. There have been some exciting changes and we'd like to introduce you to the leadership team.

)

stdClass Object ( [id] => 9 [title] => New company, new website [alias] => new-company-new-website [title_alias] => [introtext] => [language] => * [fulltext] =>

Arcinova is set to make some exciting changes to the existing business and site. Not only will there be restructuring and physical changes but we've also commissioned this brand new website to let our customers know more about us and the changes to expect.

[checked_out] => 0 [checked_out_time] => 0000-00-00 00:00:00 [catid] => 9 [created] => 2016-01-22 10:33:59 [created_by] => 849 [created_by_alias] => [modified] => 2018-07-06 14:08:23 [modified_by] => 849 [modified_by_name] => tr10.support [publish_up] => 2016-01-22 10:33:59 [publish_down] => 0000-00-00 00:00:00 [images] => {"image_intro":"images\/news2.jpg","float_intro":"","image_intro_alt":"","image_intro_caption":"","image_fulltext":"","float_fulltext":"","image_fulltext_alt":"","image_fulltext_caption":""} [urls] => {"urla":false,"urlatext":"","targeta":"","urlb":false,"urlbtext":"","targetb":"","urlc":false,"urlctext":"","targetc":""} [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [metadata] => {"robots":"","author":"","rights":"","xreference":""} [metakey] => [metadesc] => [access] => 1 [hits] => 198 [xreference] => [featured] => 0 [readmore] => 267 [state] => 1 [category_title] => News [category_route] => news [category_access] => 1 [category_alias] => news [author] => tr10.support [author_email] => support@tr10.com [contactid] => [parent_title] => ROOT [parent_id] => 1 [parent_route] => [parent_alias] => root [rating] => [rating_count] => [published] => 1 [parents_published] => 1 [alternative_readmore] => [layout] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 0 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 0 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 0 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 1 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => none [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 1 [show_category_title] => 0 [show_description] => 1 [show_description_image] => 0 [maxLevel] => 1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 0 [show_base_description] => 1 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 0 [num_intro_articles] => 9 [num_columns] => 3 [num_links] => 0 [multi_column_order] => 1 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => order [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [layout_type] => blog [menu_text] => 1 [page_title] => Latest News from Arcinova [show_page_heading] => 0 [pageclass_sfx] => news [menu-meta_description] => Find out the most recent news from the team at Arcinova. [secure] => 0 [page_description] => [page_rights] => [robots] => [access-view] => 1 ) ) [displayDate] => 2016-01-22 10:33:59 [slug] => 9:new-company-new-website [parent_slug] => [catslug] => 9:news [event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) [text] => )

stdClass Object ( [id] => 8 [title] => Press Release [alias] => acquisition [title_alias] => [introtext] =>

Arc Trinova is acquiring a site in Alnwick to form International Contract Research and Development Business.

 

 

[language] => * [fulltext] =>

ARC Trinova is acquiring site in Alnwick to form International Contract Research and Development Business.

Arc Trinova, a new company formed by Ian Shott and Paul Ryan, owners of Shott Trinova LLP, is delighted to announce the successful acquisition of the Covance Alnwick site in Northumberland, United Kingdom.The Alnwick site has focused primarily on activities that fall within the Chemistry Manufacturing and Controls (CMC) area of pharmaceutical development and this will be continued in full. Arc Trinova will add capability in Active Pharmaceutical Ingredient (API) process development and scale up to the multi-kilogram level. The new business will continue to offer Covance these services while also seeking to build a large international client base. The company will aim to deliver best in class technology in the fields of contract research, development and small scale manufacturing to maximise effectiveness whilst minimising risk and overall cost. Arc Trinova has a long term vision to grow a large and sustainable business offering this broad array of services to customers all over the world.

Ian Shott and Paul Ryan, both residents in the North East of England, have worked together for the last 15 years running businesses that operate in the global pharmaceutical market.Managing Director Ian Shott commented: “The Company considers the Alnwick site to be a large very well equipped facility that is perfectly designed to accommodate the full range of capabilities envisaged, with a staff of the highest calibre providing a strong internationally competitive platform for sustainable growth in the future”.

"The agreement with Arc Trinova provides a future for the Alnwick site and many of its staff and allows us to collaborate with Arc Trinova in certain areas linked to work performed at other Covance sites,” says Steve Street, General Manager and Global Vice President Early Development. He adds “The non-clinical business remains a key component of drug development within Covance.”

Bond Dickinson provided lead legal advice and Alistair Scott-Somers, Corporate Partner at Bond Dickinson’s Leeds office, commented: “Working with experienced deal makers like Ian Shott and Paul Ryan has been a pleasure and to be instrumental in securing the future of a business which is a key employer in the North East has been very rewarding”.

The Company has also received financial advice for this transaction from LGF Partners, a specialist debt advisory business focused on providing independent, strategic and creative debt capital raising advice to companies and management teams in the high technology and fast growth sectors. The firm raises debt capital for SME and small to mid-cap businesses in the UK, Ireland, Europe and further a field. 

 

About Arc Trinova

We are a Contract Research, Development and Manufacturing Organisation (CRDO) providing the pharmaceutical industry with comprehensive services from drug R&D through small scale manufacture.

We are focused on providing services linked to the pre-clinical to Phase I/IIa clinical development of new small molecules drug candidates, Process Development, Scale-Up and Manufacturing, covering drug candidates in Development and launched to the Market, at relatively small quantities.

We are trusted partners for our customers supporting their development and delivery programmes for new medicines in a timely and cost effective manner to sustainably improve the health and wellbeing of society.

Our mission is to deliver best in class technology services in the fields of contract research, development and small scale manufacturing to maximise effectiveness whilst minimising risk and overall cost.

Visit our Services or Facilities page to learn more about Arcinova.

[checked_out] => 0 [checked_out_time] => 0000-00-00 00:00:00 [catid] => 9 [created] => 2016-01-22 10:33:29 [created_by] => 849 [created_by_alias] => [modified] => 2018-07-06 14:07:31 [modified_by] => 849 [modified_by_name] => tr10.support [publish_up] => 2016-01-22 10:33:29 [publish_down] => 0000-00-00 00:00:00 [images] => {"image_intro":"images\/Archinova-Press-Release.jpg","float_intro":"","image_intro_alt":"","image_intro_caption":"","image_fulltext":"images\/Archinova-Press-Release.jpg","float_fulltext":"right","image_fulltext_alt":"","image_fulltext_caption":""} [urls] => {"urla":false,"urlatext":"","targeta":"","urlb":false,"urlbtext":"","targetb":"","urlc":false,"urlctext":"","targetc":""} [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [metadata] => {"robots":"","author":"","rights":"","xreference":""} [metakey] => [metadesc] => Arc Trinova is acquiring a site in Alnwick to form International Contract Research and Development Business. [access] => 1 [hits] => 3903 [xreference] => [featured] => 0 [readmore] => 4097 [state] => 1 [category_title] => News [category_route] => news [category_access] => 1 [category_alias] => news [author] => tr10.support [author_email] => support@tr10.com [contactid] => [parent_title] => ROOT [parent_id] => 1 [parent_route] => [parent_alias] => root [rating] => [rating_count] => [published] => 1 [parents_published] => 1 [alternative_readmore] => [layout] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 0 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 0 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 0 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 1 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => none [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 1 [show_category_title] => 0 [show_description] => 1 [show_description_image] => 0 [maxLevel] => 1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 0 [show_base_description] => 1 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 0 [num_intro_articles] => 9 [num_columns] => 3 [num_links] => 0 [multi_column_order] => 1 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => order [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [layout_type] => blog [menu_text] => 1 [page_title] => Latest News from Arcinova [show_page_heading] => 0 [pageclass_sfx] => news [menu-meta_description] => Find out the most recent news from the team at Arcinova. [secure] => 0 [page_description] => [page_rights] => [robots] => [access-view] => 1 ) ) [displayDate] => 2016-01-22 10:33:29 [slug] => 8:acquisition [parent_slug] => [catslug] => 9:news [event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) [text] =>

Arc Trinova is acquiring a site in Alnwick to form International Contract Research and Development Business.

 

 

)